Market Overview:
The global high content screening market reached a value of US$ 1.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2027, exhibiting a CAGR of 8.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
High content screening (HCS), also known as high-content analysis (HCA), is an automated microscopy method of identifying cellular phenotype and biological deviations. It assists in determining whether a drug candidate modifies the disease course and identifying micro-molecules such as peptides or RNAi that alter the cell morphology and phenotype. It is an advanced approach to cell-based screening in drug discovery, which combines the automated recording of multicolor fluorescence imaging and high-throughput quantitative data analysis. It allows professionals to screen and evaluate the activity of compounds on multiple epigenetic marks. As a result, HCS is widely used in pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROS).
The increasing prevalence of chronic disorders and neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, represents one of the major factors positively influencing the demand for HCS around the world. In addition, the rising aging population, which is more prone to such ailments, is contributing to the market growth. Apart from this, leading players are introducing innovative HCS equipment that is integrated with software platforms and artificial intelligence (AI) systems to improve the visualization capabilities of the screening systems. It can also be attributed to the development of automated systems for analyzing cell separation and scalability, which has further improved the adoption of HCS technology. Furthermore, they find extensive application in the pharmaceutical industry due to the escalating need for an affordable drug discovery system. Besides this, governing agencies of numerous countries are considerably investing in the research and development (R&D) of advanced screening systems, along with significant improvement in the healthcare infrastructure, which is creating a positive market outlook.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global high content screening market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on product, application and end-user.
Breakup by Product:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Instruments
- Cell Imaging and Analysis Systems
- Flow Cytometers
- Consumables
- Reagents & Assay Kits
- Microplates
- Other Consumables
- Software
- Services
- Accessories
Instruments dominate the market due to advances in instrumentation and automation techniques with advanced visualization capability and enhanced software platforms.
Breakup by Application:
- Target Identification and Validation
- Primary Screening and Secondary Screening
- Toxicity Studies
- Compound Profiling
- Other Applications
Primary screening and secondary screening currently dominates the market as primary screening helps in determining the microorganisms and organic acid in cells, whereas secondary screening assists in obtaining the quantitative and qualitative information about the cells, desired organisms or strains.
Breakup by End-User:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations (CROs)
High content screening (HCS) is widely utilized in pharmaceutical and biotechnology companies for various clinical and preclinical studies.
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
North America holds the majority of the global high content screening share due to the increasing drug discovery research in the region.
Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, General Electric, Merck KGaA, PerkinElmer, Inc., Perkinelmer Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Yokogawa India Ltd.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product, Application, End-User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific and Yokogawa Electric Corporation |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global high content screening market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global high content screening market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global high content screening market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global High Content Screening Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Instruments
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Cell Imaging and Analysis Systems
6.1.2.2 Flow Cytometers
6.1.3 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Reagents & Assay Kits
6.2.2.2 Microplates
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Software
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Services
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Accessories
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Application
7.1 Target Identification and Validation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Primary Screening and Secondary Screening
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Toxicity Studies
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Compound Profiling
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End-User
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Academic and Government Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Contract Research Organizations (CROs)
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Becton, Dickinson and Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bio-Rad Laboratories Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Biotek Instruments Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Danaher Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 GE Healthcare
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck Millipore
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Perkinelmer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Tecan Group Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Thermo Fisher Scientific
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Yokogawa Electric Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: High Content Screening Market: Major Drivers and Challenges
Figure 2: Global: High Content Screening Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: High Content Screening Market: Breakup by Product (in %), 2021
Figure 4: Global: High Content Screening Market: Breakup by Application (in %), 2021
Figure 5: Global: High Content Screening Market: Breakup by End-User (in %), 2021
Figure 6: Global: High Content Screening Market: Breakup by Region (in %), 2021
Figure 7: Global: High Content Screening Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: High Content Screening (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: High Content Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: High Content Screening (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: High Content Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: High Content Screening (Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: High Content Screening (Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: High Content Screening (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: High Content Screening (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: High Content Screening (Accessories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: High Content Screening (Accessories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: High Content Screening (Target Identification and Validation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: High Content Screening (Target Identification and Validation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: High Content Screening (Primary Screening and Secondary Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: High Content Screening (Primary Screening and Secondary Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: High Content Screening (Toxicity Studies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: High Content Screening (Toxicity Studies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: High Content Screening (Compound Profiling) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: High Content Screening (Compound Profiling) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: High Content Screening (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: High Content Screening (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: High Content Screening (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: High Content Screening (Academic and Government Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: High Content Screening (Academic and Government Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: High Content Screening (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: High Content Screening (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: North America: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: North America: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: United States: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: United States: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Canada: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Canada: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Asia Pacific: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Asia Pacific: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: China: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: China: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Japan: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Japan: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: India: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: India: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: South Korea: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: South Korea: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Australia: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Australia: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Indonesia: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Indonesia: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Others: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Europe: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Europe: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Germany: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Germany: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: France: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: France: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: United Kingdom: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: United Kingdom: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Italy: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Italy: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Spain: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Spain: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Russia: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Russia: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Latin America: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Latin America: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Brazil: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Brazil: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Mexico: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Mexico: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Others: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Others: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Middle East and Africa: High Content Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Middle East and Africa: High Content Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Global: High Content Screening Industry: SWOT Analysis
Figure 83: Global: High Content Screening Industry: Value Chain Analysis
Figure 84: Global: High Content Screening Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: High Content Screening Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: High Content Screening Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: High Content Screening Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: High Content Screening Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 5: Global: High Content Screening Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: High Content Screening Market: Competitive Structure
Table 7: Global: High Content Screening Market: Key Players